Skip to Content
Merck
  • Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs.

Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs.

Toxicology in vitro : an international journal published in association with BIBRA (2014-03-08)
Yutaka Kimura, Chizu Fujimura, Yumiko Ito, Toshiya Takahashi, Setsuya Aiba
ABSTRACT

We established a luciferase reporter assay system, the Multi-ImmunoTox Assay (MITA), to evaluate the effects on key predictivein vitro components of the human immune system. The system is composed of 3 stable reporter cell lines transfected with 3 luciferase genes, SLG, SLO, and SLR, under the control of 4 cytokine promoters, IL-2, IFN-γ, IL-1β, and IL-8, and the G3PDH promoter. We first compared the effects of dexamethasone, cyclosporine, and tacrolimus on these cell lines stimulated with phorbol 12-myristate 13-acetate and ionomycin, or lipopolysaccharides, with those on mRNA expression by the mother cell lines and human whole blood cells after stimulation. The results demonstrated that MITA correctly reflected the change of mRNA of the mother cell lines and whole blood cells. Next, we evaluated other immunosuppressive drugs, off-label immunosuppressive drugs, and non-immunomodulatory drugs. Although MITA did not detect immunosuppressive effects of either alkylating agents or antimetabolites, it could demonstrate those of the off-label immunosuppressive drugs, sulfasalazine, chloroquine, minocycline, and nicotinamide. Compared with the published immunological effects of the drugs, these data suggest that MITA can present a novel high-throughput approach to detect immunological effects of chemicals other than those that induce immunosuppressive effects through their inhibitory action on cell division.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phorbol 12-myristate 13-acetate, synthetic, ≥98.0% (TLC)
Sigma-Aldrich
Cyclosporin A, 97.0-101.5% (on dried basis)
Sigma-Aldrich
Cyclosporin A, BioReagent, from Tolypocladium inflatum, for molecular biology, ≥95%
Sigma-Aldrich
Cyclosporin A, from Tolypocladium inflatum, ≥95% (HPLC), solid
Supelco
Digoxin, analytical standard
Sigma-Aldrich
Mecamylamine hydrochloride
Sigma-Aldrich
Azathioprine, ≥98%
Sigma-Aldrich
PMA, for use in molecular biology applications, ≥99% (HPLC)
Sigma-Aldrich
Phorbol 12-myristate 13-acetate, ≥99% (TLC), film or powder
Supelco
Cyclosporin A, VETRANAL®, analytical standard
Sigma-Aldrich
Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Paracetamol, European Pharmacopoeia (EP) Reference Standard
USP
Tacrolimus, United States Pharmacopeia (USP) Reference Standard
USP
Digoxin, United States Pharmacopeia (USP) Reference Standard
Azathioprine, European Pharmacopoeia (EP) Reference Standard
Digoxin, European Pharmacopoeia (EP) Reference Standard
USP
Azathioprine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
FK-506 monohydrate, ≥98% (HPLC)
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
Supelco
Azathioprine, Pharmaceutical Secondary Standard; Certified Reference Material
Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
Digoxin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
USP
Acetaminophen, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Sulfasalazine, 97.0-101.5%
Sigma-Aldrich
Colchicine, BioReagent, suitable for plant cell culture, ≥95% (HPLC)
Sigma-Aldrich
Nicotinamide, ≥98% (HPLC), powder
Sigma-Aldrich
Niacinamide, meets USP testing specifications
Sigma-Aldrich
Mycophenolic acid, ≥98%
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Methotrexate, meets USP testing specifications